Methadone expansion in detention for staff
Part of Mental health clinical trials.
This trial studies how to make methadone treatment available in jails and prisons by working with staff who might help implement it. If you work in a correctional facility and are involved in security, medical, or budget decisions, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must work for a jail or prison system (carceral system).
- Your job involves security, medical care, or budget/administration in that system.
- You are interested in or already helping to start methadone treatment in your facility.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how to best increase the use of medication for opioid use disorder (MOUD) in jails or prisons. Sites that join will test ways to start or expand access to these life-saving treatments.
This trial tests a new way to help people get methadone treatment by working with staff at opioid treatment programs. It might lead to better access for patients.
This trial offers buprenorphine (a medication for opioid use disorder) to people in jail who are soon to be released. It helps you start treatment while incarcerated and continue it after you return to the community, aiming to reduce overdose and improve recovery.
This study tests a system to improve care for people with opioid use disorder as they leave jail and return to the community. It aims to help patients stay in treatment and avoid interruptions.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This study tests whether a combination of buprenorphine (a medication for opioid addiction) and PrEP (a daily pill to prevent HIV) can help people who are leaving jail or prison stay healthy. It aims to reduce both opioid relapse and HIV risk during the transition back to the community.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.